Cargando…
Double-blind, placebo-controlled trial of mifepristone on cognition and depression in alcohol dependence
BACKGROUND: Alcohol dependence is a significant issue contributing to disease burden. Changes in cortisol concentrations during alcohol withdrawal are associated with cognitive deficits and symptoms of depression. Current treatments are only successful for a small proportion of people and do not tar...
Autores principales: | Donoghue, Kim, Rose, Abigail, Coulton, Simon, Coleman, Rachel, Milward, Joanna, Philips, Thomas, Drummond, Colin, Little, Hilary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493392/ https://www.ncbi.nlm.nih.gov/pubmed/32938477 http://dx.doi.org/10.1186/s13063-020-04726-z |
Ejemplares similares
-
Double-blind, 12 month follow-up, placebo-controlled trial of mifepristone on cognition in alcoholics: the MIFCOG trial protocol
por: Donoghue, Kim, et al.
Publicado: (2016) -
Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial
por: Esteve, Josep Lluis Carbonell, et al.
Publicado: (2013) -
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial
por: Chu, Justin J, et al.
Publicado: (2020) -
Developing Typologies of User Engagement With the BRANCH Alcohol-Harm Reduction Smartphone App: Qualitative Study
por: Milward, Joanna, et al.
Publicado: (2018) -
Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
por: Hamel, Charlotte, et al.
Publicado: (2021)